P Greenland, SC Smith Jr, SM Grundy - Circulation, 2001 - Am Heart Assoc Enthusiasm for primary prevention and risk assessment in asymptomatic people has
been spurred by recent advances in prevention research. Lipid-lowering trials
demonstrated that primary prevention of coronary events is feasible, ... Cited by 323 - Related articles - BL Direct - All 7 versions
HD Aronow, EJ Topol, MT Roe, PL Houghtaling … - The Lancet, 2001 - Elsevier Lipid-lowering therapy was associated with a smaller proportion of deaths at 30
days (17 [0·5%] vs 179 [1·0%], hazard ratio 0·44 [95% Cl 0·27–0·73],
p=0·001) and at 6 months (63 [1·7%] vs 605 [3·5%], 0·48 [0·37–0·63] ... Cited by 301 - Related articles - BL Direct - All 10 versions
WC Willett - Science, 2002 - sciencemag.org Genetic and environmental factors, including diet and life-style, both
contribute to cardiovascular disease, cancers, and other major causes of
mortality, but various lines of evidence indicate that environmental ... Cited by 298 - Related articles - BL Direct - All 9 versions
- ►diabetesjournals.org [PDF] MM Engelgau, KM Narayan, WH Herman - Diabetes Care, 2000 - Am Diabetes Assoc In 1997, nearly 16 million people in the US had diabetes (1,2). Of this
population, 10.3 million were diag- nosed and 5.4 million were undiagnosed
(1,2). In the future, these numbers are expected to increase substantially ... Cited by 221 - Related articles - All 9 versions
- ►newportbodyscan.com [PDF] MJ Pletcher, JA Tice, M Pignone, WS Browner - Archives of Internal Medicine, 2004 - Am Med Assoc Methods We systematically searched electronic databases for relevant articles
published between January 1, 1980, and March 19, 2003, and hand searched
bibliographies. We included studies that reported measuring the coronary ... Cited by 194 - Related articles - BL Direct - All 8 versions
AD Federman, AS Adams, D Ross-Degnan, SB … - Jama, 2001 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Cost-sharing in ... Cited by 140 - Related articles - BL Direct - All 5 versions
AM Fendrick, DG Smith, ME Chernew, SN … - American Journal of Managed Care, 2001 - sph.umich.edu Prescription drug coverage is a critical agenda item on the healthcare policy
landscape. Increasing utilization of available drugs, cou- pled with the
sustained development and marketing of innovative products, is largely ... Cited by 123 - Related articles - View as HTML - BL Direct - All 7 versions
- ►ahajournals.org DB Mark, MA Hlatky - Circulation, 2002 - Am Heart Assoc Healthcare costs have been rising in the United States, as they have in the rest
of the developed world, for decades. Although many factors contribute to this
rise, a major cause is the continued development of new and more expensive ... Cited by 98 - Related articles - BL Direct - All 7 versions
EA Kerr, SL Krein, S Vijan, TP Hofer, RA … - American Journal of Managed Care, 2001 - ajmc.com Eve A. Kerr, MD, MPH; Sarah L. Krein, PhD, RN; Sandeep Vijan, MD, MS; Timothy P.
Hofer, MD, MS; and Rodney A. Hayward, MD ... Current Efforts to Measure the
Quality of Healthcare In 1997, the President's Advisory Commission on ... Cited by 91 - Related articles - View as HTML - BL Direct - All 3 versions
LY Wang, Q Yang, R Lowry, H Wechsler - Obesity, 2003 - nature.com Research Methods and Procedures: Standard cost-effectiveness analysis methods
and a societal perspective were used in this study. Three categories of costs
were measured: intervention costs, medical care costs associated with ... Cited by 86 - Related articles - BL Direct - All 7 versions
